Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

Asthma-II: Pathophysiology and Classification

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:

Asthma: Pathogenesis and Management

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.

Inflammation

Inflammation

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

Pneumonia II: Pathophysiology

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The importance of symptoms in bronchiectasis.

European respiratory review : an official journal of the European Respiratory Society·2026

Same author

ERS statement: Core outcome set for trials evaluating the management of community-acquired and nosocomial pneumonia in adults.

The European respiratory journal·2026

Same author

Participant experience of a low-carbon, hybrid 'spoke-and-hub', small-format lung health conference.

ATS scholar·2026

Same author

Mucoactive therapies and the European Respiratory Society guideline for adult bronchiectasis: what now after the CLEAR trial?

The European respiratory journal·2026

Same author

Bronchiectasis in Italy: an analysis of the EMBARC registry.

ERJ open research·2026

Same author

<i>S</i> <i>taphylococcus aureus</i> in bronchiectasis: epidemiology, clinical impact and challenges in management.

ERJ open research·2026

Same journal

Implementing acute exacerbations of COPD care bundles: evidence, effectiveness and future directions.

European respiratory review : an official journal of the European Respiratory Society·2026

Same journal

Preclinical human models of primary ciliary dyskinesia.

European respiratory review : an official journal of the European Respiratory Society·2026

Same journal

Bench evidence, bedside uncertainty: hyperoxia, mechanical ventilation and lung injury.

European respiratory review : an official journal of the European Respiratory Society·2026

Same journal

Respiratory support in paediatric patients with bronchiolitis: a systematic review and meta-analysis.

European respiratory review : an official journal of the European Respiratory Society·2026

Same journal

Air pollution-induced airway epithelial barrier dysfunction in COPD: a narrative review of mechanisms and therapeutic implications.

European respiratory review : an official journal of the European Respiratory Society·2026

Same journal

Utilising human cellular models of primary ciliary dyskinesia: a scoping review.

European respiratory review : an official journal of the European Respiratory Society·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 17, 2025

A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide

A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide

Published on: December 15, 2014

Neutrophilic inflammation in bronchiectasis.

James D Chalmers¹, Mark Metersky², Stefano Aliberti^3,4

¹Division of Molecular and Clinical Medicine, University of Dundee, Dundee, UK.

European Respiratory Review : an Official Journal of the European Respiratory Society

|April 2, 2025

Summary

This summary is machine-generated.

Neutrophil-driven inflammation fuels bronchiectasis, a chronic lung disease. Targeting this inflammation offers a promising therapeutic strategy for improving patient outcomes in bronchiectasis.

More Related Videos

Methodology for Sputum Induction and Laboratory Processing

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

In vitro Coculture Assay to Assess Pathogen Induced Neutrophil Trans-epithelial Migration

In vitro Coculture Assay to Assess Pathogen Induced Neutrophil Trans-epithelial Migration

Published on: January 6, 2014

Related Experiment Videos

Last Updated: May 17, 2025

A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide

A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide

Published on: December 15, 2014

Methodology for Sputum Induction and Laboratory Processing

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

In vitro Coculture Assay to Assess Pathogen Induced Neutrophil Trans-epithelial Migration

In vitro Coculture Assay to Assess Pathogen Induced Neutrophil Trans-epithelial Migration

Published on: January 6, 2014

Area of Science:

Pulmonology
Immunology
Pathophysiology

Background:

Bronchiectasis is a chronic, progressive lung disease characterized by cough, sputum, and recurrent infections.
Its progression is driven by a cycle of inflammation, infection, impaired mucociliary clearance, and lung damage.

Purpose of the Study:

To review the critical role of neutrophil-driven inflammation in bronchiectasis pathogenesis and progression.
To explore neutrophilic inflammation as a potential therapeutic target.

Main Methods:

Literature review focusing on the mechanisms of neutrophil involvement in bronchiectasis.
Analysis of the relationship between neutrophil apoptosis, protease release, and disease severity.

Main Results:

Delayed neutrophil apoptosis and increased necrosis contribute to sustained inflammation in bronchiectasis.
Excessive release of neutrophil proteases (elastase, cathepsin G, proteinase 3) creates a protease-antiprotease imbalance, worsening inflammation and disease progression.

Conclusions:

Neutrophilic inflammation is central to bronchiectasis pathogenesis.
Targeting neutrophil-driven inflammation presents a novel therapeutic avenue for bronchiectasis with potential for significant clinical benefit.